Immunomodulator and Biologic Agent Effects on Sleep Quality in Patients With Inflammatory Bowel Disease

REFERENCES

1. ↵
   1. Zimmerman J.

   Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms. Dig Dis Sci. 2003 4; 48 4: 743- 749. pmid:12741465

   OpenUrlCrossRefPubMed
2. ↵
   1. Ananthakrishnan AN.,
   2. Long MD.,
   3. Martin CF.,
   4. Sandler RS.,
   5. Kappelman MD.

   Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013 8; 11 8: 965- 971. doi: 10.1016/j.cgh.2013.01.021. pmid:23376797

   OpenUrlCrossRefPubMed
3. 1. Ali T.,
   2. Madhoun MF.,
   3. Orr WC.,
   4. Rubin DT.

   Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013 10; 19 11: 2440- 2443. doi: 10.1097/MIB.0b013e3182a0ea54. pmid:23945186

   OpenUrlCrossRefPubMed
4. ↵
   1. Gingold-Belfer R.,
   2. Peled N.,
   3. Levy S.,
   4. et al.

   Impaired sleep quality in Crohn's disease depends on disease activity. Dig Dis Sci. 2014 1; 59 1: 146- 151. doi: 10.1007/s10620-013-2890-8. pmid:24114045

   OpenUrlCrossRefPubMed
5. ↵
   1. Pace F.,
   2. Molteni P.,
   3. Bollani S.,
   4. et al.

   Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol. 2003 10; 38 10: 1031- 1038. pmid:14621276

   OpenUrlCrossRefPubMed
6. ↵
   1. Ranjbaran Z.,
   2. Keefer L.,
   3. Farhadi A.,
   4. Stepanski E.,
   5. Sedghi S.,
   6. Keshavarzian A.

   Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007 11; 22 11: 1748- 1753. pmid:17914945

   OpenUrlCrossRefPubMed
7. ↵
   1. Keefer L.,
   2. Stepanski EJ.,
   3. Ranjbaran Z.,
   4. Benson LM.,
   5. Keshavarzian A.

   An initial report of sleep disturbance in inactive inflammatory bowel disease. J Clin Sleep Med. 2006 10 15; 2 4: 409- 416. pmid:17557469

   OpenUrlPubMed
8. ↵
   1. Uthgenannt D.,
   2. Schoolmann D.,
   3. Pietrowsky R.,
   4. Fehm HL.,
   5. Born J.

   Effects of sleep on the production of cytokines in humans. Psychosom Med. 1995 Mar-Apr; 57 2: 97- 104. pmid:7792381

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Shoham S.,
   2. Davenne D.,
   3. Cady AB.,
   4. Dinarello CA.,
   5. Krueger JM.

   Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol. 1987 7; 253 1 Pt 2: R142- R149. pmid:3496800

   OpenUrlPubMed
10. ↵
    1. Abad VC.,
    2. Sarinas PS.,
    3. Guilleminault C.

    Sleep and rheumatologic disorders. Sleep Med Rev. 2008 6; 12 3: 211- 28. doi: 10.1016/j.smrv.2007.09.001. pmid:18486034

    OpenUrlCrossRefPubMedWeb of Science
11. 1. Chandrasekhara PK.,
    2. Jayachandran NV.,
    3. Rajasekhar L.,
    4. Thomas J.,
    5. Narsimulu G.

    The revalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol. 2009; 19 4: 407- 415. doi: 10.1007/s10165-009-0185-x. pmid:19521744

    OpenUrlCrossRefPubMed
12. ↵
    1. Brass SD.,
    2. Duquette P.,
    3. Proulx-Therrien J.,
    4. Auerbach S.

    Sleep disorders in patients with multiple sclerosis. Sleep Med Rev. 2010 4; 14 2: 121- 129. doi: 10.1016/j.smrv.2009.07.005. pmid:19879170

    OpenUrlCrossRefPubMed
13. ↵
    1. Wells G.,
    2. Li T.,
    3. Maxwell L.,
    4. Maclean R.,
    5. Tugwell P.

    Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis. 2008 2; 67 2: 260- 265. pmid:17846044

    OpenUrlAbstract/FREE Full Text
14. 1. Ruperto N.,
    2. Lovell DJ.,
    3. Li T.,
    4. et al.

    Paediatric Rheumatology International Trials Organisation (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG). Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2010 11; 62 11: 1542- 1551. doi: 10.1002/acr.20283. pmid:20597110

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Karadağ O.,
    2. Nakas D.,
    3. Kalyoncu U.,
    4. Akdoğan A.,
    5. Kiraz S.,
    6. Ertenli I.

    Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol Int. 2012 7; 32 7: 1909- 1913. doi: 10.1007/s00296-011-1907-x. pmid:21448640

    OpenUrlCrossRefPubMed
16. ↵
    1. Vgontzas AN.,
    2. Zoumakis E.,
    3. Bixler EO.,
    4. et al.

    Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004 5; 89 5: 2119- 2126. pmid:15126529

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Buysse DJ.,
    2. Reynolds CF 3rd.,
    3. Monk TH.,
    4. Berman SR.,
    5. Kupfer DJ.

    The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 5; 28 2: 193- 213. pmid:2748771

    OpenUrlCrossRefPubMedWeb of Science